Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial

Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial · SciRah

^aDivision of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA
^bChristopher C. Thompson, MD, MSc, Division of Gastroenterology, Brigham and Women’s Hospital, 75 Francis St, Thorn 1404, Boston, Massachusetts 02115, USA. E-mail: [email protected]
^cDivision of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital, Boston, Massachusetts, USA
^dGuarantor of the article: Christopher C. Thompson, MD, MSc, FASGE, FACG
^eSpecific author contributions: All authors were involved in the preparation of the manuscript, agreed to submit it for publication, and assumed responsibility for the accuracy and completeness of the data and the data analyses. The sponsor, Aspire Bariatrics (King of Prussia, PA, USA), performed the statistical analyses and provided editorial assistance in preparing this manuscript. Study supervision, analysis and interpretation of data, drafting of the manuscript, and critical revision of the manuscript for important intellectual content: Christopher C. Thompson
^facquisition of data: Donna Harakal, Meredith Young, Catherine E. Thomas, Alpana P. Shukla, Michele B. Ryan, and Miki Haas
^gstudy concept and design, analysis and interpretation of data, assistance in preparing the manuscript: Heidi Goldsmith and Jennifer McCrea
^hstudy supervision and critical revision of the manuscript for important intellectual content: Louis J. Aronne
ⁱstudy supervision: Robert Kushner, Shelby Sullivan, Alan B. Schorr, Anastassia Amaro, Caroline M. Apovian, Terrence Fullum, Amir Zarrinpar, Michael D. Jensen, Steven Edmundowicz, J. Matthew Bohning, Gregory Ginsberg, and David L. Jaffe
^jsubject supervision: Barham K. Abu Dayyeh, Adam C. Stein, Michel Kahaleh, Marvin Ryou, Christopher Huang, Daniel D. Tran, Joseph P. Glaser, John A. Martin, Francis A. Farraye, Samuel B. Ho, and Nitin Kumar
^kDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
^lDivision of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
^mDivision of Gastroenterology, Washington University in St Louis, St Louis, Missouri, USA
ⁿDivision of Endocrinology, St Mary Medical Center, Langhorne, Pennsylvania, USA
^oDivision of Endocrinology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
^pNutrition and Weight Management Center, Boston Medical Center, Boston, Massachusetts, USA
^qDivision of Minimally Invasive and Bariatric Surgery, Howard University, Washington, District of Columbia, USA
^rDivision of Gastroenterology, University of California, San Diego, California, USA
^sDivision of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA
^tDivision of Gastroenterology and Hepatology, Northwestern University School of Medicine, Chicago, Illinois, USA
^uWashington University in St Louis, St Louis, Missouri, USA
^vPresent address: University of Colorado Denver, Denver, CO, USA
^wDivision of Gastroenterology, Weill Cornell Medical College, New York, New York, USA
^xSpecific author contributions: All authors were involved in the preparation of the manuscript, agreed to submit it for publication, and assumed responsibility for the accuracy and completeness of the data and the data analyses. The sponsor, Aspire Bariatrics (King of Prussia, PA, USA), performed the statistical analyses and provided editorial assistance in preparing this manuscript. Study supervision, analysis and interpretation of data, drafting of the manuscript, and critical revision of the manuscript for important intellectual content: Christopher C. Thompson; study supervision and critical revision of the manuscript for important intellectual content: Louis J. Aronne; subject supervision: Barham K. Abu Dayyeh, Adam C. Stein, Michel Kahaleh, Marvin Ryou, Christopher Huang, Daniel D. Tran, Joseph P. Glaser, John A. Martin, Francis A. Farraye, Samuel B. Ho, and Nitin Kumar; study supervision: Robert Kushner, Shelby Sullivan, Alan B. Schorr, Anastassia Amaro, Caroline M. Apovian, Terrence Fullum, Amir Zarrinpar, Michael D. Jensen, Steven Edmundowicz, J. Matthew Bohning, Gregory Ginsberg, and David L. Jaffe; acquisition of data: Donna Harakal, Meredith Young, Catherine E. Thomas, Alpana P. Shukla, Michele B. Ryan, and Miki Haas; study concept and design, analysis and interpretation of data, assistance in preparing the manuscript: Heidi Goldsmith and Jennifer McCrea
^yDivision of Gastroenterology, St Mary Medical Center, Langhorne, Pennsylvania, USA
^zDivision of Gastroenterology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
^aaSection of Gastroenterology, Boston Medical Center, Boston, Massachusetts, USA
^abCenter for Wellness and Weight Loss Surgery, Howard University, Washington, District of Columbia, USA
^acVA San Diego Healthcare System, San Diego, California, USA
^adNorthwestern University School of Medicine, Chicago, Illinois, USA
^aePresent address: Mayo Clinic, Rochester, Minnesota, USA
^afSection of Gastroenterology, VA San Diego Healthcare System, San Diego, California, USA
^agWeill Cornell Medical College, New York, New York, USA
^ahBrigham and Women's Hospital, Boston, Masachusetts, USA
^aiSt Mary Medical Center, Langhorne, Pennsylvania, USA
✉Corresponding author

Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial

Abstract

Plain-language summary

Discussion